Bristol-Myers Squibb elects Dr. Deepak L. Bhatt to Board of Directors

BRISTOL MYERS SQUIBB CO

Dr. Deepak L. Bhatt elected to Board effective June 14, 2022; Board size increases to 11.
Dr. Bhatt will serve on the Science & Technology Committee.
He brings over 20 years of cardiovascular research experience; currently Executive Director at Brigham and Women's Hospital.
Compensation per standard non-employee director program: $105,000 annual retainer plus $200,000 DSU award.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Deepak L. Bhatt

Director

BMY · BRISTOL MYERS SQUIBB CO

Effective: 2022-06-14
Filed: June 15, 2022, 7:59 PM ET

On June 14, 2022, the Board of Directors (the “Board”) of Bristol-Myers Squibb Company (the “Company”) elected Mr. Deepak L. Bhatt , M.D., M.P.H., to serve as a member of the Board, effective June 14, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Deepak L. Bhatt was elected as Director at BRISTOL MYERS SQUIBB CO.

Action: elected
Role: Director

Exact text from the filing

On June 14, 2022, the Board of Directors (the “Board”) of Bristol-Myers Squibb Company (the “Company”) elected Mr. Deepak L. Bhatt , M.D., M.P.H., to serve as a member of the Board, effective June 14, 2022.

View on SEC.gov

BRISTOL MYERS SQUIBB CO filing history →

Source: SEC EDGAR

accession 0001140361-22-023069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.